Candice Internicola

Candice Internicola

Auto-generated profile, based on publicly available information

Candice Internicola

Universite Claude Bernard Lyon 1, INSERM, UMR 1033, LYOS, Lyon, France

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2026 in Bone Reports
Verified
Journal Article
Open access
ABAnne Briolay
Anne Briolay
CICandice Internicola
Candice Internicola
DCDavid Cheillan
David Cheillan
SASophie Ayciriex
Sophie Ayciriex
OPOlivier Peyruchaud
Olivier Peyruchaud
CBCarole Bougault
Carole Bougault

4 April 2025 in bioRxiv
Verified
Preprint
Open access
MEMathias Emery
Mathias Emery
CCCinthia-Nayeli Cuero
Cinthia-Nayeli Cuero
LBLamia Bouazza
Lamia Bouazza
CICandice Internicola
Candice Internicola
FDFrançois Duboeuf
François Duboeuf
OPOlivier Peyruchaud
Olivier Peyruchaud
Autotaxin (ATX) is a lysophospholipase D (lysoPLD) serving as both a lysophosphatidic acid (LPA)-producing enzyme and a LPA docking molecule. ATX binds to the cell surface via interaction with adhesive molecules, including β1-integrin, potentially facilitating LPA access to its specific G protein-coupled receptors. However, the precise protein-protein interaction sequences and their biological implications remain unknown. Here, we identify the interaction domains between ATX and β1-integrin and generate specific blocking antibodies allowing to demonstrate that ATX-β1 binding domain involves a cryptic epitope unmasked by LPA docking. In addition, whereas anti-ATX antibodies do not inhibit the lysoPLD activity, immunological neutralization of the ATX-β1 integrin binding site reduces arthritis development in a collagen-induced arthritis model. These findings offer novel insights into the molecular mechanisms governing ATX functions, which, in addition to its enzymatic activity, requires cell surface binding. These findings suggest that ATX binding domains could be targeted for novel therapeutic approaches.